Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$62.63 - $80.22 $2.3 Million - $2.94 Million
-36,659 Closed
0 $0
Q2 2019

Aug 01, 2019

SELL
$61.87 - $69.38 $1.1 Million - $1.24 Million
-17,802 Reduced 32.69%
36,659 $2.48 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $2.24 Million - $2.73 Million
-30,773 Reduced 36.1%
54,461 $4.11 Million
Q2 2017

Aug 11, 2017

BUY
N/A
85,234
85,234 $6.03 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Amica Mutual Insurance CO Portfolio

Follow Amica Mutual Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amica Mutual Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Amica Mutual Insurance CO with notifications on news.